News
MR-141 Met Primary And All Secondary Endpoints, Demonstrating Rapid And Sustained Improvement In Near Visual Acuity Without Compromising Distance Vision ...
India's clinical trial industry has surged into the top three globally, driven by regulatory reforms, affordability, vast ...
With technology/AI taking over administrative and repetitive tasks, human roles will shift towards more strategic, creative, ...
ST-100 shows promise as a fast-acting treatment for dry eye disease, offering rapid relief and unique collagen repair ...
The government has permitted Dr. Cameron Lacey, a psychiatrist, to prescribe psilocybin, a hallucinogenic compound found in ...
Antisense-based therapy salanersen (BIIB115/ION306) is a possible follow-up to Biogen's big-selling Spinraza (nusinersen) therapy for SMA, which has come under pressure from increased competition in ...
Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis ...
Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...
More than 8 million people globally suffer from type 1 diabetes, a condition where the immune system destroys ...
A Stanford-led phase 3 trial shows gene therapy skin grafts significantly heal chronic wounds in patients with severe ...
Testosterone therapy did not improve walking distance in older women recovering from hip fracture compared to exercise alone, ...
Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades from the South African Medical Research Council for their groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results